SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-013384
Filing Date
2020-03-27
Accepted
2020-03-27 08:00:19
Documents
5
Period of Report
2020-05-06
Effectiveness Date
2020-03-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A torc-def14a_20200506.htm DEF 14A 758863
2 GRAPHIC goq2fuxibqvu000004.jpg GRAPHIC 58357
3 GRAPHIC goq2fuxibqvu000001.jpg GRAPHIC 5658
4 GRAPHIC goq2fuxibqvu000002.jpg GRAPHIC 5893
5 GRAPHIC goq2fuxibqvu000003.jpg GRAPHIC 58886
  Complete submission text file 0001564590-20-013384.txt   937841
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38359 | Film No.: 20748062
SIC: 2834 Pharmaceutical Preparations